药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cryptenamine
Imidapril
Desipramine may decrease the antihypertensive activities of Imidapril.
Cryptenamine
Angiotensin 1-7
Desipramine may decrease the antihypertensive activities of Angiotensin 1-7.
Cryptenamine
Rauwolfia serpentina root
Desipramine may decrease the antihypertensive activities of Rauwolfia serpentina root.
Cryptenamine
Trimazosin
Desipramine may decrease the antihypertensive activities of Trimazosin.
Cryptenamine
Temocapril
Desipramine may decrease the antihypertensive activities of Temocapril.
Cryptenamine
Ferulic acid
Desipramine may decrease the antihypertensive activities of Ferulic acid.
Cryptenamine
Diethylnorspermine
Desipramine may decrease the antihypertensive activities of Diethylnorspermine.
Cryptenamine
Dexpropranolol
Desipramine may decrease the antihypertensive activities of Dexpropranolol.
Cryptenamine
Spirapril
Desipramine may decrease the antihypertensive activities of Spirapril.
Cryptenamine
Saprisartan
Desipramine may decrease the antihypertensive activities of Saprisartan.
Cryptenamine
Cilazapril
Desipramine may decrease the antihypertensive activities of Cilazapril.
Cryptenamine
Terazosin
Desipramine may decrease the antihypertensive activities of Terazosin.
Cryptenamine
Deserpidine
Desipramine may decrease the antihypertensive activities of Deserpidine.
Cryptenamine
Cryptenamine
Desipramine may decrease the antihypertensive activities of Cryptenamine.
Mefenamic acid
Lithium hydroxide
The risk or severity of serotonin syndrome can be increased when Nefazodone is combined with Lithium hydroxide.
Mefenamic acid
Lithium citrate
The risk or severity of serotonin syndrome can be increased when Lithium citrate is combined with Nefazodone.
Mefenamic acid
Lithium carbonate
The risk or severity of serotonin syndrome can be increased when Nefazodone is combined with Lithium carbonate.
Mefenamic acid
Pralsetinib
The serum concentration of Nefazodone can be increased when it is combined with Pralsetinib.
Mefenamic acid
Satralizumab
The serum concentration of Nefazodone can be decreased when it is combined with Satralizumab.
Mefenamic acid
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Nefazodone is combined with Oliceridine.